<DOC>
	<DOCNO>NCT02773784</DOCNO>
	<brief_summary>- This prospective , single-center , non-randomized , non-controlled study . - The estrogen receptor ( ER ) , progesterone receptor ( PgR ) , HER2 status Ki67 index CNB specimen critical biomarkers make neoadjuvant therapy strategy invasive breast cancer . The concordance biomarkers CNB surgical specimen vary previous retrospective report . The aim study determine discordance biomarkers CNB surgical specimen influence make treatment strategy discordance .</brief_summary>
	<brief_title>Comparison CNB Surgical Specimens ER , PgR , HER2 Status Ki67 Index Invasive Breast Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>• histologically confirm primary invasive breast cancer core needle biopsy • pathological diagnose ductal carcinoma situ microinvasive breast cancer core needle biopsy patient plan receive neoadjuvant system therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>